Literature DB >> 18823173

Insulin receptor substrate-2 in the ventral tegmental area regulates behavioral responses to cocaine.

Sergio D Iñiguez1, Brandon L Warren, Rachael L Neve, Eric J Nestler, Scott J Russo, Carlos A Bolaños-Guzmán.   

Abstract

Neurotrophic factor signaling modulates cellular and behavioral responses to drugs of abuse. Among other biochemical adaptations, chronic exposure to abused drugs decreases the expression of insulin receptor substrate-2 (IRS-2; a protein involved in neurotrophic signaling) in the ventral tegmental area (VTA), a neural substrate for many drugs of abuse. Using viral-mediated gene transfer to locally alter the activity of IRS-2, the authors show that overexpression of IRS-2 in the VTA results in an enhanced preference for environments previously paired with cocaine, as measured by the place conditioning paradigm, whereas blockade of IRS-2 activity results in avoidance of cocaine-paired compartments. In addition, IRS-2 overexpression leads to enhanced cocaine-induced locomotor activity, and blockade of IRS-2 expression significantly blunts behavioral responses to cocaine. These results demonstrate that levels of IRS-2 in the VTA regulate responsiveness to the behavioral effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823173      PMCID: PMC2562620          DOI: 10.1037/a0012893

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  42 in total

Review 1.  Opponent process properties of self-administered cocaine.

Authors:  Aaron Ettenberg
Journal:  Neurosci Biobehav Rev       Date:  2004-01       Impact factor: 8.989

2.  Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.

Authors:  L Sklair-Tavron; W X Shi; S B Lane; H W Harris; B S Bunney; E J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

3.  The origin and distribution of dopamine-containing afferents to the rat frontal cortex.

Authors:  P C Emson; G F Koob
Journal:  Brain Res       Date:  1978-02-24       Impact factor: 3.252

4.  Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus.

Authors:  R L Neve; J R Howe; S Hong; R G Kalb
Journal:  Neuroscience       Date:  1997-07       Impact factor: 3.590

5.  Cortical and limbic dopamine (on opiate addiction): do not mix before use!

Authors:  G Di Chiara
Journal:  Trends Pharmacol Sci       Date:  1997-03       Impact factor: 14.819

6.  The use of place conditioning in studying the neuropharmacology of drug reinforcement.

Authors:  D C Hoffman
Journal:  Brain Res Bull       Date:  1989 Oct-Nov       Impact factor: 4.077

Review 7.  Molecular mechanisms of drug addiction: adaptations in signal transduction pathways.

Authors:  E J Nestler; M T Berhow; E S Brodkin
Journal:  Mol Psychiatry       Date:  1996-07       Impact factor: 15.992

Review 8.  Neurobiology of opiate abuse.

Authors:  G Di Chiara; R A North
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

9.  Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat.

Authors:  V Bassareo; G Tanda; P Petromilli; C Giua; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

Review 10.  Neurotrophic factors: from molecule to man.

Authors:  R M Lindsay; S J Wiegand; C A Altar; P S DiStefano
Journal:  Trends Neurosci       Date:  1994-05       Impact factor: 13.837

View more
  17 in total

Review 1.  Common cellular and molecular mechanisms in obesity and drug addiction.

Authors:  Paul J Kenny
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

2.  Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.

Authors:  Brandon L Warren; Sergio D Iñiguez; Lyonna F Alcantara; Katherine N Wright; Eric M Parise; Sarah K Weakley; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

3.  Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.

Authors:  Lyonna F Alcantara; Brandon L Warren; Eric M Parise; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Psychopharmacology (Berl)       Date:  2014-01-23       Impact factor: 4.530

4.  Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.

Authors:  Eric M Parise; Lyonna F Alcantara; Brandon L Warren; Katherine N Wright; Roey Hadad; Omar K Sial; Kyle G Kroeck; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2013-06-19       Impact factor: 13.382

5.  Viral-mediated expression of extracellular signal-regulated kinase-2 in the ventral tegmental area modulates behavioral responses to cocaine.

Authors:  Sergio D Iñiguez; Brandon L Warren; Rachael L Neve; Scott J Russo; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  Behav Brain Res       Date:  2010-06-01       Impact factor: 3.332

6.  Post-training cocaine exposure facilitates spatial memory consolidation in C57BL/6 mice.

Authors:  Sergio D Iñiguez; Sergios Charntikov; Shelley A Baella; Matthew S Herbert; Carlos A Bolaños-Guzmán; Cynthia A Crawford
Journal:  Hippocampus       Date:  2011-05-03       Impact factor: 3.899

7.  Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates responses to stress.

Authors:  Sergio D Iñiguez; Vincent Vialou; Brandon L Warren; Jun-Li Cao; Lyonna F Alcantara; Lindsey C Davis; Zarko Manojlovic; Rachael L Neve; Scott J Russo; Ming-Hu Han; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

8.  Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood.

Authors:  Sergio D Iñiguez; Lyonna F Alcantara; Brandon L Warren; Lace M Riggs; Eric M Parise; Vincent Vialou; Katherine N Wright; Genesis Dayrit; Steven J Nieto; Matthew B Wilkinson; Mary K Lobo; Rachael L Neve; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

Review 9.  Insulin, leptin and reward.

Authors:  Jon F Davis; Derrick L Choi; Stephen C Benoit
Journal:  Trends Endocrinol Metab       Date:  2009-10-07       Impact factor: 12.015

Review 10.  Intranasal Insulin: a Treatment Strategy for Addiction.

Authors:  Bhavani Kashyap; Leah R Hanson; William H Frey Ii
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.